Target intelligence / Profile preview

Ankyrin repeat domain 20 family member A8, pseudogene (ANKRD20A8P)

Target
ANKRD20A8P
Molecular classification
Other (Pseudogene; not a functional protein-coding gene)
01

Overview

Ankyrin repeat domain 20 family member A8, pseudogene (ANKRD20A8P) is a member of the ankyrin repeat domain-containing gene family, annotated as a pseudogene in humans[1][3][6][7]. ANKRD20A8P does not encode a functional protein, and there is no evidence of it acting as a receptor, enzyme, or other classical drug target[1][3][7]. Its sequences are related to other ankyrin repeat domain proteins, but as a pseudogene, it is generally understood to lack biological activity attributable to protein function[1][3]. There is no documented relevance as a therapeutic target, no associated interacting drugs, no described mechanism of drug action, and it is not used as a clinical biomarker. The gene is included in several gene and protein databases for reference and comparative genomics but does not have characterized molecular or physiological roles[1][3][7]. Pseudogenes like ANKRD20A8P can sometimes possess non-coding RNA functions, such as acting as microRNA decoys or regulatory elements, but there is no evidence of such a role for ANKRD20A8P specifically[1][3][4]. The abundance of alternative names largely stems from differences in database nomenclature, historical annotations, or sequence similarity to functional genes within the ankyrin repeat domain family[3].

Other names
Ankyrin repeat domain-containing protein 20BANKRD20BAnkyrin repeat domain-containing protein 20A pseudogeneAnkyrin repeat domain 20BAnkyrin repeat domain protein 18A pseudogene
02

Biological functions

Other (No known protein-coding or biochemical function; general role as a non-coding RNA is possible but not established for this locus)
03

Disease associations

Other (No direct or established disease involvement; as a pseudogene, no verified disease linkage)

Beyond the preview

Go deeper on Ankyrin repeat domain 20 family member A8, pseudogene (ANKRD20A8P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain 20 family member A8, pseudogene (ANKRD20A8P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call